Alexion Pharmaceuticals
Alexion Pharmaceuticals, Inc.
121 Seaport Blvd
Boston, MA 02210
Phone: 1-475-230-2596Website: https://alexion.com/Careers: alexion.com/your-career...Patient Assistance Program: alexion.com/our-medicines...
Latest news
- FDA Approves Expanded Use of Soliris (eculizumab) for Pediatric Myasthenia Gravis, Bringing New Treatment Options for Children
10 March 2025 - Ultomiris Approved in the US for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder (NMOSD)
25 March 2024 - Ultomiris Approved in the US for Adults with Generalised Myasthenia Gravis
28 April 2022 - Alexion Announces FDA Approval of Ultomiris (ravulizumab-cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)
7 June 2021 - Alexion Receives FDA Approval for New Advanced Formulation of Ultomiris (ravulizumab-cwvz) with Significantly Reduced Infusion Time
12 October 2020 - Alexion Receives FDA Approval for Ultomiris (ravulizumab-cwvz) for Atypical Hemolytic Uremic Syndrome (AHUS)
18 October 2019 - Alexion Receives FDA Approval of Soliris (eculizumab) for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder
27 June 2019 - FDA Approves Ultomiris (ravulizumab-cwvz) for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)
21 December 2018 - Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
19 June 2018 - FDA Approves Soliris (eculizumab) for the Treatment of Patients with Generalized Myasthenia Gravis (gMG)
23 October 2017
Drugs Associated with Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 5 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Kanuma
Generic name: sebelipase alfa Drug class: lysosomal enzymes |
||
|
Soliris
Generic name: eculizumab Drug class: selective immunosuppressants |
3 reviews | 7.3 / 10 |
|
Strensiq
Generic name: asfotase alfa Drug class: miscellaneous metabolic agents |
||
|
Ultomiris
Generic name: ravulizumab Drug class: selective immunosuppressants |
7 reviews | 9.6 / 10 |
|
Voydeya
Generic name: danicopan Drug class: selective immunosuppressants |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||